ClinConnect ClinConnect Logo
Search / Trial NCT05125939

Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study

Launched by EVERGREEN GENERAL HOSPITAL, TAIWAN · Nov 7, 2021

Trial Information

Current as of August 22, 2025

Recruiting

Keywords

Colonoscopy Adenoma Detection Rate Screening

ClinConnect Summary

This clinical trial is studying whether the overall adenoma detection rate (ADR) during a colonoscopy can be a good substitute for the screening adenoma detection rate. Essentially, researchers want to find out if measuring how well doctors find adenomas (which are growths that can sometimes turn into cancer) during colonoscopies for various reasons—like checking for cancer or monitoring existing issues—can replace the specific detection rate used for screening purposes alone.

To be part of this study, you need to be at least 50 years old and scheduled for a colonoscopy. However, certain individuals are not eligible, including those with specific family histories of colorectal cancer, certain syndromes, or other serious conditions affecting the colon. If you join the study, you can expect to undergo a routine colonoscopy, and your results will help researchers determine the best ways to detect adenomas in the future. It’s important to know that the study is currently looking for participants, and your involvement would contribute valuable information to improve colorectal health practices.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • consecutive patients aged ≥50 years undergoing colonoscopy are eligible for enrollment.
  • Exclusion Criteria:
  • high risk family history of colorectal cancer (CRC) e.g., familial adenomatous polyposis, hereditary non-polyposis CRC syndrome, multiple first degree relatives with CRC, or a single first degree relative with CRC at \<60 years
  • serrated polyposis syndrome
  • inflammatory bowel disease
  • colonoscopy to remove a large neoplastic polyps
  • obstructive lesions of the colon
  • gastrointestinal bleeding
  • current participation in other studies
  • hospitalized patients
  • mental retardation
  • pregnancy
  • refusal to provide a written informed consent.

About Evergreen General Hospital, Taiwan

Evergreen General Hospital, located in Taiwan, is a leading healthcare institution dedicated to advancing medical research and clinical innovation. With a strong commitment to patient care and safety, the hospital actively sponsors clinical trials aimed at evaluating new treatments and interventions across various medical disciplines. Leveraging a multidisciplinary team of experienced clinicians and researchers, Evergreen General Hospital fosters a collaborative environment that promotes groundbreaking studies and enhances the understanding of healthcare practices. The institution adheres to the highest ethical standards and regulatory guidelines, ensuring rigorous trial design and execution to contribute valuable insights to the global medical community.

Locations

Kaohsiung, , Taiwan

Taoyuan, , Taiwan

Taoyuan, , Taiwan

Keelung, , Taiwan

North Hills, California, United States

Kaohsiung, , Taiwan

Patients applied

0 patients applied

Trial Officials

Chi-Liang Cheng

Principal Investigator

Evergreen General Hospital, Taoyuan, Taiwan

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials